Sustainable advantage Position Evolutia Bio as a provider of sustainable bio-based ingredient production through precision fermentation, highlighting cost efficiency and higher product purity versus traditional extraction or chemical synthesis to target consumer care, food & beverage, and pharmaceutical customers seeking greener supply chains.

Strategic partnerships Leverage recent collaboration momentum with Laurus Labs and PharmaCentral noted in 2024 to propose co-development or contract manufacturing partnerships, emphasizing access to diverse ingredients and expanded scale for potential enterprise customers.

Enzyme and process focus Target customers interested in enzyme development and scalable bioprocesses by promoting Evolutia Bio’s capability to engineer organisms for specialized ingredients, offering a pathway to optimize workflows, reduce reliance on petrochemical routes, and enable confidential IP development.

Funding and momentum Capitalize on announced financing rounds and corporate updates as proof of ongoing R&D momentum, using it to approach investee-like prospects or strategic buyers seeking validated innovation pipelines and nearer-term revenue potential.

Global expansion readiness Highlight readiness to support international scale with a Bay Area biotech footprint and collaboration-ready tech stack, appealing to multinational consumer goods and pharma players seeking lower-risk, nearshore to offshore capabilities with high-purity bio-based ingredients.